Dréno, B., Ascierto, P. A., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., . . . Ribas, A. (2018). Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF(V600) mutation–positive melanoma. Br J Cancer.
Chicago Style CitationDréno, Brigitte, et al. "Health-related Quality of Life Impact of Cobimetinib in Combination With Vemurafenib in Patients With Advanced or Metastatic BRAF(V600) Mutation–positive Melanoma." Br J Cancer 2018.
Cita MLADréno, Brigitte, et al. "Health-related Quality of Life Impact of Cobimetinib in Combination With Vemurafenib in Patients With Advanced or Metastatic BRAF(V600) Mutation–positive Melanoma." Br J Cancer 2018.
Atenció: Aquestes cites poden no estar 100% correctes.